No abstract available
Keywords:
3D bioprinting; biosealants; clinical trial; cornea; decellularized tissues; fillers; ocular disorders; short peptide.
Grants and funding
The author(s) declare financial support was received for the research, authorship, and/or publication of this article. Project PID2021-128985OB-I00 funded by MCIN/AEI/10.13039/501100011033/FEDER Una manera de hacer Europa, is acknowledged. FR-O acknowledges funding from Plan Andaluz de Investigacion, “Desarrollo e Innovacion” (PAIDI2020) Fellowship supported by Consejería de Economía, Conocimiento, Empresas y Universidad, Junta de Andalucía co-funded by Fondo Social Europeo de Andalucía 2014-2020.